THC THERAPEUTICS, INC. Selling, General and Administrative Expense
THC THERAPEUTICS, INC. reported Selling, General and Administrative Expense of $3.42 thousand for the 3-month period ending 2023-04-30, per its 10-Q filed 2024-01-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2024-01-09
- THC THERAPEUTICS, INC. selling, general and administrative expense for the quarter ending 2023-04-30 was $3.42K, a 89.76% decline year-over-year.
- THC THERAPEUTICS, INC. selling, general and administrative expense for the quarter ending 2023-01-31 was $58.03K, a 10.11% increase year-over-year.
- THC THERAPEUTICS, INC. selling, general and administrative expense for the quarter ending 2022-10-31 was $7.79K, a 87.52% decline year-over-year.
- THC THERAPEUTICS, INC. selling, general and administrative expense for the quarter ending 2022-07-31 was -$10.32K, a 122.94% decline year-over-year.
- THC THERAPEUTICS, INC. selling, general and administrative expense for fiscal 2022 was $138.28K, a 35.08% decline from fiscal 2021.
- THC THERAPEUTICS, INC. selling, general and administrative expense for fiscal 2021 was $212.99K.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 9 month as first filed | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|---|---|---|
| 2023-04-30 | $3.42K 10-Q · filed 2024-01-09 | $61.45K derived: sum of 2 quarters · filed 2024-01-09 | $69.24K 10-Q · filed 2024-01-09 | $58.92K derived: sum of 4 quarters · filed 2024-01-09 | |||
| 2023-01-31 | $58.03K 10-Q · filed 2024-01-08 | $65.82K 10-Q · filed 2024-01-08 | $55.49K derived: sum of 3 quarters · filed 2024-01-08 | $88.94K derived: sum of 4 quarters · filed 2024-01-09 | |||
| 2022-10-31 | $7.79K 10-Q · filed 2022-12-22 | -$2.53K derived: sum of 2 quarters · filed 2022-12-22 | $30.91K derived: sum of 3 quarters · filed 2024-01-09 | $83.61K derived: sum of 4 quarters · filed 2024-01-09 | |||
| 2022-07-31 | -$10.32K derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-25 | $23.12K derived: sum of 2 quarters · filed 2024-01-09 | $75.82K derived: sum of 3 quarters · filed 2024-01-09 | $138.28K 10-K · filed 2022-11-25 | |||
| 2022-04-30 | $33.44K 10-Q · filed 2024-01-09 | $86.14K derived: sum of 2 quarters · filed 2024-01-09 | $148.60K 10-Q · filed 2024-01-09 | $193.61K derived: sum of 4 quarters · filed 2024-01-09 | |||
| 2022-01-31 | $52.70K 10-Q · filed 2024-01-08 | $115.16K 10-Q · filed 2024-01-08 | $160.16K derived: sum of 3 quarters · filed 2024-01-08 | $241.37K derived: sum of 4 quarters · filed 2024-01-08 | |||
| 2021-10-31 | $62.46K 10-Q · filed 2022-12-22 | $107.47K derived: sum of 2 quarters · filed 2022-12-22 | $188.68K derived: sum of 3 quarters · filed 2022-12-22 | $235.65K derived: sum of 4 quarters · filed 2022-12-22 | |||
| 2021-07-31 | $45.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-25 | $126.21K derived: sum of 2 quarters · filed 2022-11-25 | $173.19K derived: sum of 3 quarters · filed 2022-11-25 | $212.99K 10-K · filed 2022-11-25 | |||
| 2021-04-30 | $81.21K 10-Q · filed 2022-06-16 | $77.22K 10-Q · filed 2021-06-22 | $128.18K derived: sum of 2 quarters · filed 2022-06-16 | $167.99K 10-Q · filed 2022-06-16 | $155.75K 10-Q · filed 2021-06-22 | ||
| 2021-01-31 | $46.98K 10-Q · filed 2022-05-16 | $42.85K 10-Q · filed 2021-03-29 | $86.78K 10-Q · filed 2022-05-16 | $78.53K 10-Q · filed 2021-03-29 | |||
| 2020-10-31 | $39.81K 10-Q · filed 2022-05-16 | $35.68K 10-Q · filed 2020-12-17 | |||||
| 2020-04-30 | $49.85K 10-Q · filed 2021-06-22 | $81.94K derived: sum of 2 quarters · filed 2021-06-22 | $145.64K 10-Q · filed 2021-06-22 | ||||
| 2020-01-31 | $32.08K 10-Q · filed 2021-03-29 | $95.79K 10-Q · filed 2021-03-29 | |||||
| 2019-10-31 | $63.70K 10-Q · filed 2020-12-17 |